BMS-986094,1234490-83-5

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BMS-986094

CAS No. : 1234490-83-5

MCE 国际站：BMS-986094

产品活性：BMS-986094 (INX-08189) 是丙型肝炎病毒 (HCV) 有效抑制剂，在 Huh-7 细胞中，抑制 HCV 复制的 EC₅₀ 值为 35 nM (24 h)。BMS-986094 是 6-O-methyl-2’-C-methyl guanosine 的氨基磷酸酯前体，可用于慢性 HCV 感染的研究。

研究领域：Anti-infection

作用靶点：HCV

In Vitro: BMS-986094 (INX-08189) is a highly potent inhibitor of HCV replication, with the EC₅₀s of 10 nM against genotype 1b, 12 nM against genotype 1a, and 0.9 nM against genotype 2a after 72 h of exposure. And the concentration resulting in 50% cellular cytotoxicity (CC₅₀) in cultured Huh-7 cells is 7.01 μM.
BMS-986094 (5-80 nM; 14 days) decreases luciferase activity in a concentration-dependent manner in genotype 1b replicon cells.
BMS-986094 (20 μM; 3 days ) decreases relative mitochondrial copy number of 11% in CEM cells. BMS-986094 (1 μM; 14 days ) has no effect on mitochondrial copy number in CEM cells. BMS-986094 does not alter the relative mitochondrial copy number in HepG2 cells.
MS-986094 (10 µM; 24 hours) does not increase apparently in the concentration of BMS-986094 or its metabolites in human hepatocytes (HHs) and human cardiomyocytes (HCMs) except that intracellular concentrations of INX-09114 increases and plateaues after a 7-hour incubation in HCM.

In Vivo: BMS-986094 (3-300 mg/kg; p.o.) converts to 2′-C-Me-GTP after oral administration, and 2’-C-MeG in the plasma is proportional to the production of 2’-C-MeGTP in the liver.
BMS-986094 (25 mg/kg; p.o.) is efficiently extracts from the portal circulation by the liver following oral administration in cynomolgus monkeys.
BMS-986094 (15 or 30 mg/kg/d; p.o. for 3 weeks) administers cynomolgus monkeys, the nucleoside metabolite M2 was the major plasma analyte, and INX-09114 was the highest drug-related species in the heart and kidney.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Clinical Compound Library  |  Antiviral Compound Library  |  Drug Repurposing Compound Library  |  Orally Active Compound Library  |  Anti-Hepatitis C Virus Compound Library  |  Heterocyclic Compound Library  |  Resiquimod  |  Honokiol  |  Ribavirin  |  Deferiprone  |  U18666A  |  AG-1478  |  Artemisinin  |  EIDD-1931  |  Asunaprevir  |  Myriocin  |  Grazoprevir  |  Simeprevir  |  NIM811  |  Sofosbuvir  |  RO8191  |  Vesatolimod  |  GS-443902 trisodium  |  Glecaprevir  |  BLT-1  |  Mizoribine  |  Daclatasvir  |  Ledipasvir  |  Alisporivir  |  Boceprevir  |  Cyclo(Phe-Pro)  |  Azvudine hydrochloride  |  Telaprevir  |  NHC-triphosphate tetraammonium  |  Danoprevir  |  Elbasvir

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds